Dr. Heta Turunen Discusses Zenalpha: A Novel Sedative Agent for Dogs - Ep. 3

How often do we get innovative new drugs in the veterinary anesthesia field these days? In this episode, host and veterinary anesthesiologist, Dr. Bonnie Gatson is joined by Dr. Heta Turunen, veterinarian and clinical researcher at Vetcare Oy, to discuss the newly developed and recently approved sedative agent, Zenalpha [https://www.dechra-us.com/our-products/us/companion-animal/dog/prescription/zenalpha-medetomidine-and-vatinoxan-hydrochlorides-injection]. Together, they discuss the clinical effects of alpha-2 adrenergic agents and just how different Zenalpha is compared to drugs in the same class such as medetomidine and dexmedetomidine. Learn how to utilize this new sedative drug effectively in your practice while brushing up on your general knowledge of alpha-2 adrenergic agents in small animal patients. If you like what you hear, consider becoming a member [https://www.mynavas.org/plans-pricing] of the North American Veterinary Anesthesia Society (NAVAS) for access to more anesthesia and analgesia educational and RACE-approved CE content. Thank you to our sponsor, Dechra [https://www.dechra-us.com/] - learn more about the pharmaceutical products Dechra has to offer veterinary professionals, such as Zenalpha. You can expect a new episode on the 15th, or just after, of each month. If you have question about this episode or if you want to suggest topics for future episodes, please reach out to the producers of this podcast at [email protected]. Special thanks to Chris Webster, Saul Jimenez, and Maria Bridges for making this podcast a reality.